Fig. 1

Expression of UBE2W in various human tumors. a Increased expression of UBE2W in different tumors compared to normal tissues in the Oncomine database. b UBE2W expression of different tumor types from the TCGA database was investigated by TIMER (*P < 0.05, **P < 0.01, ***P < 0.001). c UBE2W was abnormally expressed in pan cancers by TNMplot. Significant differences by Mann-Whitney U test are marked with red color. Abbreviations: ACC: adrenocortical carcinoma; BLCA: bladder urothelial carcinoma; BRCA: breast invasive carcinoma; CESC: cervical squamous cell carcinoma; CHOL: cholangiocarcinoma; COAD: colon adenocarcinoma; DLBC: lymphoid neoplasm diffuse large B cell lymphoma; ESCA: esophageal carcinoma; GBM: glioblastoma multiforme; LGG: brain lower grade glioma; HNSC: head and neck squamous cell carcinoma; KICH: kidney chromophobe; KIRC: kidney renal clear cell carcinoma; KIRP: kidney renal papillary cell carcinoma; LAML: acute myeloid leukemia; LIHC: liver hepatocellular carcinoma; LUAD: lung adenocarcinoma; LUSC: lung squamous cell carcinoma; MESO: mesothelioma; OV: ovarian serous cystadenocarcinoma; PAAD: pancreatic adenocarcinoma; PCPG: pheochromocytoma and paraganglioma; PRAD: prostate adenocarcinoma; READ: rectum adenocarcinoma; SARC: sarcoma; SKCM: skin cutaneous melanoma; STAD: stomach adenocarcinoma; TGCT: testicular germ cell tumors; THCA: thyroid carcinoma; THYM: thymoma; UCEC: uterine corpus endometrial carcinoma; UCS: uterine carcinosarcoma; and UVM: uveal melanoma; AML: ; Lung_AC: lung adenocarcinoma; Lung_SC: lung squamous cell carcinoma; Renal_CC: renal clear cell carcinoma; Renal_CH: renal chromophobe cell carcinoma; Renal_PA: renal papillary cell carcinoma; Uterus_CS: uterine carcinosarcoma; Uterus_EC: uterine corpus endometrial carcinoma